BioPharma Resources

Drug Trial Radar · NCT05035641

A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

A Pilot Phase II Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Ranging, Safety and Efficacy Study of Oral AND017 to Treat Anemia in Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients

Last checked: Nov 19, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 113 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

113

Actual

Start

Oct 18, 2021

Primary completion

Jul 5, 2023

Study completion Jul 24, 2023

Sponsor

Lead sponsor
Kind Pharmaceuticals LLCIndustry
Sponsor type
Industry
First posted
Sep 5, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 20 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a pilot phase II study to evaluate the safety and efficacy of AND017 in NDD-CKD patients

Conditions

  • Renal Anemia

Interventions

  • AND017Drug

    Orally, 3 times per week in Period 1 and randomize to TIW or QW group at the same dose in Period 2

  • PlaceboDrug

    Orally, 3 times per week

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety EvaluationsTime frame: Up to 17 weeks
  2. Rate of rise in hemoglobin for each of 3 dose levels as compared with placebo from baseline to 5 weeks after TIW oral dosingTime frame: Up to 5 weeks after dosing

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Amicis Research Center

    Northridge, California

  • Clinical Site Partners

    Winter Park, Florida

  • Northwest Louisiana Nephrology

    Shreveport, Louisiana

  • Elite Research Center

    Flint, Michigan

  • Metrolina Nephrology Associates

    Charlotte, North Carolina

  • Southeast Renal Research Institute

    Chattanooga, Tennessee

  • Clinical Advancement Center, PLLC

    San Antonio, Texas

  • Peking University People's Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.